Researchers at La Trobe University have built a sensor that mimics the protective surface of gut cells and, in lab tests, ...

Yorkshire-based life sciences firm Aptamer Group has announced the launch of a new programme to develop targeted ...

Aptamer Group launched a targeted radiopharmaceutical development programme on Wednesday, expanding its pipeline in a ...

Researchers at Osaka Metropolitan University along with their international collaborators report that they have developed a nanofluidic device capable of capturing single proteins stochastically and ...

Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, today announced a commercial partnership with Mologic, a leading developer and manufacturer of lateral flow and rapid ...

Single-stranded molecules of DNA called “aptamers” have been studied since 1990 for their ability to bind and inhibit molecular targets, a useful behavior for disease detection and drug delivery ...

Nanomedicine. 2013;8(6):983-993. Fan and coworkers reported novel multicolor fluorescent Apt–AuNPs for homogeneous detection of small-molecule targets. [45] First, the multicolor dye-labeled aptamers ...

(RTTNews) - Aptamer Group (P0J.F, APTA.L) and Alphazyme, a Maravai LifeSciences (MRVI) company, have entered into a licensing agreement for a developed Optimer for use in hot-start PCR applications.